Cargando…

Paxlovid–tacrolimus drug–drug interaction caused severe diarrhea that induced combined diabetic ketoacidosis and a hyperglycemic hyperosmolar state in a kidney transplant patient: a case report

BACKGROUND: Transplant recipients are at high risk of coronavirus disease 2019, and a timely supply of antivirals should be prioritized for those patients. Complicated drug‒drug interactions limit the use of Paxlovid (nirmatrelvir/ritonavir) coadministered with tacrolimus. Here, we report a patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Wei, He, Yu, Wei, Mao Gang, Lu, Guang Bing, Yi, Qun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518083/ https://www.ncbi.nlm.nih.gov/pubmed/37742028 http://dx.doi.org/10.1186/s13256-023-04135-1

Ejemplares similares

Overlap of diabetic ketoacidosis and hyperosmolar hyperglycemic state
por: Hassan, Esraa Mamdouh, et al.
Publicado: (2022)

Diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome after renal transplantation in the United States
por: Abbott, Kevin C, et al.
Publicado: (2003)

Combined Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State Associated With COVID 19
por: Naranjo, José Martín Alanís, et al.
Publicado: (2021)

PSUN194 Inpatient Outcomes of Combined Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State
por: Silgado, Maria Laura Ricardo, et al.
Publicado: (2022)

Rhabdomyolysis in Pediatric Patients With Diabetic Ketoacidosis or Hyperglycemic Hyperosmolar State: A Case Series
por: Mercer, Shelly, et al.
Publicado: (2016)

Tacrolimus Drug–Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin
por: Sindelar, Morganne, et al.
Publicado: (2022)

Paxlovid-Tacrolimus Drug–Drug Interaction in a 23-Year-Old Female Kidney Transplant Patient with COVID-19
por: Berar Yanay, Noa, et al.
Publicado: (2022)

A Case of Combined Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State in a Patient With COVID-19
por: Rafique, Shemitha, et al.
Publicado: (2020)

Paxlovid with Caution: Novel Case of Paxlovid-Induced Tacrolimus Toxicity in a Cardiac Transplant Patient
por: Shah, Aaisha, et al.
Publicado: (2022)

Predictors of Recurrent Hospital Admission for Patients Presenting With Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State
por: Bradford, Annabel L., et al.
Publicado: (2017)

63. Prognosis of COVID-19 Patients with Diabetic Ketoacidosis with or Without Hyperosmolar Hyperglycemic State
por: Chan, Kok Hoe, et al.
Publicado: (2020)

Hyperosmolar Therapy for Diabetic Hyperosmolar Ketoacidosis
por: Heldeweg, Micah LA, et al.
Publicado: (2022)

Combined Hyperglycemic Hyperosmolar Syndrome and Diabetic Ketoacidosis Associated with COVID-19 in a Pediatric Patient
por: Tseng, Yu Shan, et al.
Publicado: (2021)

PSUN242 Severe Hypernatremia in a patient with combined Hyperosmolar Hyperglycemic State and Diabetic Ketoacidosis
por: Batch, Jennifer, et al.
Publicado: (2022)

COVID-19 Viral Infection Presenting With Diabetic Ketoacidosis, Hyperosmolar Hyperglycemic Syndrome, or Mixed Hyperglycemic Crisis: A Case Series
por: Patel, Dhruv, et al.
Publicado: (2023)

Comment on “Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin”
por: de Oliveira, Luciana Mello, et al.
Publicado: (2023)

Treatment of Diabetic Ketoacidosis (DKA)/Hyperglycemic Hyperosmolar State (HHS): Novel Advances in the Management of Hyperglycemic Crises (UK Versus USA)
por: Dhatariya, Ketan K., et al.
Publicado: (2017)

COVID-19 and Combined Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar Nonketotic Coma: Report of 11 Cases
por: Singh, Balraj, et al.
Publicado: (2021)

ODP225 Mixed Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar Syndrome with recent diagnosis of Diabetes Mellitus.
por: Adyanthaya, Sindhoora, et al.
Publicado: (2022)

DRUG INTERACTION BETWEEN PAXLOVID AND TACROLIMUS IN AN ADOLESCENT WITH INFLAMMATORY BOWEL DISEASE
por: Zaarur, Leenoy, et al.
Publicado: (2023)

Response to Comment on “Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin”
por: Sindelar, Morganne, et al.
Publicado: (2023)

Severe Hypernatremia in Combined Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State: A Case Report of Two Japanese Children
por: Shima, Saho, et al.
Publicado: (2020)

Paxlovid (Nirmatelvir/Ritonavir) and Tacrolimus Drug-Drug Interaction in a Kidney Transplant Patient with SARS-2-CoV infection: A Case Report
por: Prikis, Marios, et al.
Publicado: (2022)

Reversible global hypoperfusion in an adult patient with a mixed diabetic ketoacidosis/hyperglycemic hyperosmolar coma: A case report
por: Petroulia, Valentina Dafni, et al.
Publicado: (2022)

345. Acute Onset Diabetic Ketoacidosis/Hyperosmolar Hyperglycemic State in Patients Taking Integrase Strand Transfer Inhibitors
por: Ntem-Mensah, Afua Duker, et al.
Publicado: (2019)

Monitoring tacrolimus toxicity following Paxlovid administration in a liver transplant patient
por: Maynard, Robert D., et al.
Publicado: (2023)

Drug Interaction Between Tacrolimus and Paxlovid (Nirmatrelvir/Ritonavir) in an Adolescent with Inflammatory Bowel Disease
por: Zaarur, Leenoy, et al.
Publicado: (2023)

Homonymous quadrantanopia associated with hyperosmolar hyperglycemic syndrome
por: Mizuguchi, Chika, et al.
Publicado: (2020)

Hyperglycemic hyperosmolar state causing multiple thrombosis
por: Ganaw, Adel E., et al.
Publicado: (2019)

COVID-19 Vaccine and Hyperosmolar Hyperglycemic State
por: Abu-Rumaileh, Mohammed A, et al.
Publicado: (2021)

Limb Ischemia in a Patient with Hyperosmolar Hyperglycemic State
por: Al Hazmi, Ahmed, et al.
Publicado: (2018)

SAT060 Hyperosmolar Hyperglycemic State Presenting As Seizures
por: Faber, Alexis, et al.
Publicado: (2023)

Lurasidone‐induced hyperosmolar hyperglycemic syndrome: A case report
por: Hanyu, Shota, et al.
Publicado: (2022)

End-Stage Renal Disease Increases Rates of Adverse Glucose Events When Treating Diabetic Ketoacidosis or Hyperosmolar Hyperglycemic State
por: Schaapveld-Davis, Caitlin M., et al.
Publicado: (2017)

Treatment of acute tacrolimus toxicity with phenytoin after Paxlovid (nirmatrelvir/ritonavir) administration in a kidney transplant recipient
por: Kwon, Eun-Jeong, et al.
Publicado: (2022)

Case Report: tacrolimus toxicity in the setting of concurrent Paxlovid use in a heart-transplant recipient
por: Modi, Sujal, et al.
Publicado: (2023)

Severe hypernatremia in soft drink ketoacidosis and hyperglycemic hyperosmolar state at the onset of type 2 diabetes mellitus: a case series of three adolescents
por: Choo, Soo Jeong, et al.
Publicado: (2022)

Muscle relaxant induced pancreatitis leading to hyperosmolar hyperglycemic state
por: Bao, Yicheng K, et al.
Publicado: (2019)

Hyperglycemic hyperosmolar state in an adolescent with type 1 diabetes mellitus
por: Watanabe, Suguru, et al.
Publicado: (2019)

Hyperosmolar hyperglycemic state in children: case report and review of the literature
por: Shahramian, Iraj, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1t3vp3pcj26obudsl1eef6lob4